The present invention relates to compounds of the formula ##STR00001##
which are useful in treating diseases characterized by the hyperactivity
of MEK.Accordingly the compounds are useful in the treatment of diseases,
such as, cancer, cognative and CNS disorders and inflammatory/autoimmune
diseases.